Association of the glycemic background patterns and the diabetes management efficacy in poorly controlled type 2 diabetes

Table 9 Medication utilization after 12 months: Glycated hemoglobin ≤ 7% vs glycated hemoglobin > 7%, n (%)

Medication	Usage	HbA1c ≤ 7%	HbA1c > 7%	P value
MTF	Yes	34 (89.5)	70 (74.5)	0.046a
	No	4 (10.5)	24 (25.5)
DPP-IV	Yes	24 (63.2)	66 (70.2)	0.431
	No	14 (36.8)	28 (29.8)
SGLT2	Yes	29 (76.3)	72 (76.6)	0.973
	No	9 (23.7)	22 (23.4)
Pioglitazone	Yes	16 (42.1)	36 (38.3)	0.685
	No	22 (57.9)	58 (61.7)
Basal insulin	Yes	4 (10.5)	33 (35.1)	0.004a
	No	34 (89.5)	61 (64.9)
Basal-bolus insulin	Yes	1 (2.6)	18 (19.1)	0.014a
	No	37 (97.4)	76 (80.9)
Mixed insulin	Yes	0 (0)	14 (14.9)	0.012a
	No	38 (100)	80 (85.1)

^aP < 0.05.

MTF: Metformin; DPP-IV: Dipeptidyl peptidase IV inhibitors; SGLT2: Sodium-glucose transport protein 2 inhibitors.